Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Koronis Pharmaceuticals Inc.
DescriptionOral prodrug of KP-1212, a small molecule nucleoside analog that works through Viral Decay Acceleration (VDA)
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection in patients who have failed prior therapy; Treat HIV-1 infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today